Anti-VEGF

Phase III Trials in Wet AMD—What’s Next?

A look at the drugs and devices closest to the clinical-trial finish line in the United States.
11/05/2020

Debating Anti-VEGF Injections

Here’s why comprehensive ophthalmologists shouldn’t inject—or why they should.
09/09/2020

An Extra Push for Wet AMD Patients

Conventional and not-so-conventional treatments to consider when these patients don’t respond to initial anti-VEGF therapy.
08/10/2020